What is the official ID of this bill?

The official print number for this legislation is HR 2433.

When did the legislative process begin?

The process officially started on 2025-03-27.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/119/bills/hr2433/BILLS-119hr2433ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

Who is the primary sponsor?

The primary sponsor is Rep. Green, Mark E. [R-TN-7].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: ASSUMING FIRST SPONSORSHIP - Mr. Murphy asked unanimous consent that he may hereafter be considered as the first sponsor of H.R. 2433, a bill originally introduced by Representative Green (TN), for the purpose of adding cosponsors and requesting reprintings pursuant to clause 7 of rule XII. Agreed to without objection.

Analysis and Potential Impact of HR 2433

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Improved Healthcare Access: Physician Decisions in Medicare

Q: What are the main provisions?

Key points include: Medicare treatment approval decisions will be made exclusively by physicians, not by insurance companies. Insurance companies must base their decisions on clear, written medical criteria consistent with generally accepted standards. All new rules for treatment approval must be announced in advance and publicly available on websites. Insurance companies will be required to publish statistics on approved and denied treatment requests, increasing transparency.

This act aims to speed up access to medical care for Medicare beneficiaries. It introduces changes to ensure that decisions on treatment necessity are made by physicians, not solely by insurance companies. This means citizens can expect faster approvals for procedures and medications, reducing unnecessary delays in care.

Key points

Medicare treatment approval decisions will be made exclusively by physicians, not by insurance companies.

Insurance companies must base their decisions on clear, written medical criteria consistent with generally accepted standards.

All new rules for treatment approval must be announced in advance and publicly available on websites.

Insurance companies will be required to publish statistics on approved and denied treatment requests, increasing transparency.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Introduced

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Reducing Medically Unnecessary Delays in Care Act of 2025

Print number: HR 2433

Sponsor: Rep. Green, Mark E. [R-TN-7]

Process start date: 2025-03-27

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash

Source data: api.congress.gov

AI work logs for this document launch